Multiple myeloma is a cancer in which plasma cells, which normally produce antibodies, multiply uncontrollably in the bone marrow. There is currently no cure. However, various therapies can stabilise the disease and alleviate symptoms. One such therapy is to treat the patient with their own stem cells. This often involves weeks in hospital. Using machine learning methods, a research team has now assessed the conditions in which some of the therapy can be safely carried out as an outpatient. The study was conducted by researchers from the Göttingen Campus Institute for Dynamics of Biological Networks (CIDBN) at the University of Göttingen, the University Medical Center Göttingen (UMG), and the University Medical Center Bielefeld (OWL). It was published in the journal npj digital medicine.